(R)-4-Benzyl-2-(4-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole
98%
- Product Code: 229194
CAS:
2828432-20-6
Molecular Weight: | 306.28 g./mol | Molecular Formula: | C₁₆H₁₃F₃N₂O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | 417.6±45.0 °C(Predicted) | |
Density: | 1.30±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C, light-proof, inert gas |
Product Description:
Used as a chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors. Its oxazole core and trifluoromethylpyridine moiety enhance binding selectivity and metabolic stability. Commonly employed in asymmetric synthesis due to the R-configuration, enabling high enantiomeric purity in final drug compounds. Also applied in the preparation of kinase inhibitors for oncology research.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | $167.99 |
+
-
|
(R)-4-Benzyl-2-(4-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole
Used as a chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors. Its oxazole core and trifluoromethylpyridine moiety enhance binding selectivity and metabolic stability. Commonly employed in asymmetric synthesis due to the R-configuration, enabling high enantiomeric purity in final drug compounds. Also applied in the preparation of kinase inhibitors for oncology research.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :